For more information about this solicitation please see the Guide Notice NOT-OD-15-130 .
NIH/NCI 341: Development of Metabolomics Data Integration Methods and Software
NIH/NCI 342: Validation of Mobile Technologies for Clinical Assessment, Monitoring, and Intervention
NIH/NCI 343: An Electronic Platform for Cognitive Assessment in Cancer Patients
NIH/NCI 344: Technologies for Differential Isolation of Exosomes and Oncosomes
NIH/NCI 345: Predictive Biomarkers of Adverse Reactions to Radiation Treatment
NIH/NCI 346: Molecularly Targeted Radiation Therapy For Cancer Treatment
NIH/NCI 347: Signal Amplification to Enable Attomolar Quantitation in Slide-Based or ELISA Biomarker Immunoassays
NIH/NCI 348: Identification and Capture of Enriched Tumor Zones with Preservation of Labile Biomarkers from Ultra-Cold Biopsies
NIH/NCI 349: Proximity Slide Based Sandwich Immunoassay to Visualize Intramolecular Epitopes of Analytes in Tissue Sections
NIH/NCI 350: Highly Innovative Tools for Quantifying Redox Effector Dynamics in Cancer
NIH/NCI 351: Modulating the Microbiome to Improve Efficacy of Cancer Therapeutics
NIH/NCI 352: Cell and Animal-Based Models to Advance Cancer Health Disparity Research
NIH/NCI 353: Cell-Free Nucleic Acid-Based Assay Development for Cancer Diagnosis
NIH/NCI 354: Companion Diagnostics for Cancer Immunotherapies
View past contract opportunities.